11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

Recent Progress of Imaging Agents for Parkinson’s Disease

(2015) Xiaoai Wu et al.   Current Neuropharmacology

Use of 11C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

(2015) L. Appel et al.   JOURNAL OF NUCLEAR MEDICINE

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio

(2011) Marios Politis et al.   MOVEMENT DISORDERS

Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study

(2011) Nicola Pavese et al.   NEUROIMAGE

[18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease

(2011) N. Pavese et al.   NEUROIMAGE

FSL

(2011) Mark Jenkinson et al.   NEUROIMAGE

Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models

(2010) Chie Seki et al.   ANNALS OF NUCLEAR MEDICINE

Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I

(2010) M. Ziebell et al.   JOURNAL OF NUCLEAR MEDICINE

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

(2010) Marios Politis et al.   NEUROBIOLOGY OF DISEASE

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

(2009) R. Nandhagopal et al.   BRAIN

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen

(2009) Anna Brück et al.   MOVEMENT DISORDERS

The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function

(2009) Alice Egerton et al.   NEUROIMAGE

Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [11C]PE2I: Quantitative Modeling and Test—Retest Reproducibility

(2008) Jussi Hirvonen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

(2008) S SMITH et al.   NEUROIMAGE

Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study

(2007) Robert Y. Moore et al.   NEUROBIOLOGY OF DISEASE